Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan vs Amlodipine Extension Study in Hypertension
NCT00351130Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2006
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of valsartan in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoint: Percentage of patients who reach BP goal (systolic <140 mmHg and diastolic <90 mmHg) at 22 weeks. Started Jun 2006; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00351130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351130.